Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Cipla
Dow
Fish and Richardson
Express Scripts
Farmers Insurance
Harvard Business School
Mallinckrodt
QuintilesIMS

Generated: October 24, 2017

DrugPatentWatch Database Preview

DOXYLAMINE SUCCINATE Drug Profile

« Back to Dashboard

What is the patent landscape for Doxylamine Succinate, and what generic Doxylamine Succinate alternatives are available?

Doxylamine Succinate is a drug marketed by Copley Pharm, Quantum Pharmics, LNK, Perrigo, and Actavis Labs Fl Inc. and is included in five NDAs.

The generic ingredient in DOXYLAMINE SUCCINATE is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.

Summary for Tradename: DOXYLAMINE SUCCINATE

US Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list32
Bulk Api Vendors: see list47
Clinical Trials: see list182
Patent Applications: see list633
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOXYLAMINE SUCCINATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Copley Pharm
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL088900-002Feb 12, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL040167-001Sep 18, 1996OTCNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL088603-001Aug 7, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Lnk
DOXYLAMINE SUCCINATE
doxylamine succinate
TABLET;ORAL040564-001Aug 27, 2004OTCNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
doxylamine succinate; pyridoxine hydrochloride
TABLET, DELAYED RELEASE;ORAL205811-001Aug 19, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Merck
McKesson
Harvard Business School
Boehringer Ingelheim
Federal Trade Commission
Moodys
Accenture
Healthtrust
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot